First‐line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non‐squamous non‐small cell lung cancer

BACKGROUND: Epidermal growth factor receptor (EGFR) mutation positive (M+) non‐small cell lung cancer (NSCLC) is an important subtype of lung cancer comprising 10% to 15% of non‐squamous tumours. This subtype is more common in women than men, is less associated with smoking, but occurs at a younger...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cochrane Database Syst Rev
Autors principals: Greenhalgh, Janette, Boland, Angela, Bates, Victoria, Vecchio, Fabio, Dundar, Yenal, Chaplin, Marty, Green, John A
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons, Ltd 2021
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8092455/
https://ncbi.nlm.nih.gov/pubmed/33734432
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD010383.pub3
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars